Deferred Tax Assets, Valuation Allowance of Twist Bioscience Corp from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Twist Bioscience Corp quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Twist Bioscience Corp Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Sep 2025 was $383,378,000, a 6.3% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Twist Bioscience Corp Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $383,378,000 +$22,784,000 +6.3% 30 Sep 2025 10-K 17 Nov 2025 2025 FY
Q3 2024 $360,594,000 +$58,213,000 +19% 30 Sep 2024 10-K 17 Nov 2025 2025 FY
Q3 2023 $302,381,000 +$61,721,000 +26% 30 Sep 2023 10-K 18 Nov 2024 2024 FY
Q3 2022 $240,660,000 +$50,232,000 +26% 30 Sep 2022 10-K 21 Nov 2023 2023 FY
Q3 2021 $190,428,000 +$63,092,000 +50% 30 Sep 2021 10-K/A 05 Jun 2023 2022 FY
Q3 2020 $127,336,000 +$42,738,000 +51% 30 Sep 2020 10-K 23 Nov 2021 2021 FY
Q3 2019 $84,598,000 +$28,440,000 +51% 30 Sep 2019 10-K 27 Nov 2020 2020 FY
Q3 2018 $56,158,000 30 Sep 2018 10-K 13 Dec 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.